US-listed company Processa is evaluating corporate cryptocurrency financial strategies
Foresight News reports that U.S. pharmaceutical company Processa (NASDAQ: PCSA) has announced a strategic investment, though the specific amount was not disclosed, and is currently evaluating a corporate cryptocurrency financial strategy. The company has engaged LifeSci Capital as an advisor to assist in implementing the related strategy. Processa stated that it will explore the use of blockchain assets to support its clinical development projects, strictly adhering to regulatory standards.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Piedmont Realty Trust prices USD 200 million exchangeable senior notes offering due 2031
Multicoin Capital deposits another 333,200 HYPE, worth $26.73 million, to a certain exchange.
JPMorgan raises IREN target price to $65
Sharp enters Japan AI server market, takes orders for Nvidia-powered systems
Crypto prices
More
